$32.54
0.932.94%
Last update: Nov 12, 4:00 PM
Sanara MedTech Inc
SMTINASDAQ
Sanara MedTech rose 54.1% from $21.11 to $32.54, ahead of the S&P 500's +11.2%. Its worst day was Mar 25 (−9.6%), and its low came Mar 25 at $16.34.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.09 beat the $-0.23 estimate on $26.3M revenue (est. $26.6M).
0.0% · S&P 500 +0.1%
Sanara MedTech shares rose 8.6%, while the S&P 500 fell 0.1%.
Story events cover the past 12 months · Times ET
+8.6% · S&P 500 −0.1%
Sanara MedTech shares rose 9.9%, while the S&P 500 rose 0.9%.
+9.9% · S&P 500 +0.9%
EPS of $0.09 missed the $0.11 estimate on $27.5M revenue (est. $27.4M); FY revenue guidance of $116.0M–$121.0M against the $118.6M consensus.
−1.4% · S&P 500 −0.3%
EPS of $0.05 beat the $-0.18 estimate on $27.8M revenue (est. $26.8M); Q2 revenue guidance of $28.5M–$29.5M against the $28.8M consensus.
+13.4% · S&P 500 −0.2%
Sanara MedTech shares rose 13.7%, while the S&P 500 fell 1.5%.
+13.7%, the year's best day · S&P 500 −1.5%
EPS of $-0.05 beat the $-0.05 estimate on $28.1M revenue (est. $29.0M).
+0.4% · S&P 500 −0.3%
Sanara MedTech closed at its highest level of the year, 67.1% above where the year started.
+0.3% · S&P 500 0.0%
Where it ended: a close of $32.54 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $0.03, revenue est. $29.7M).
Nothing in the past 12 months.
All SMTI dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SMTI and SPY from Benzinga historical bars. Not investment advice.
